NATCO PHARMA
|
NATCO PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹4,764 Cr | ₹4,332 Cr | ₹2,881 Cr | ₹2,216 Cr | ₹2,084 Cr |
| Sales | ₹4,718 Cr | ₹3,958 Cr | ₹2,799 Cr | ₹1,947 Cr | ₹1,697 Cr |
| Job Work/ Contract Receipts | ₹1.10 Cr | ₹0.90 Cr | ₹7.60 Cr | ₹4.60 Cr | ₹10 Cr |
| Processing Charges / Service Income | ₹27 Cr | ₹353 Cr | ₹65 Cr | ₹225 Cr | ₹15 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹18 Cr | ₹20 Cr | ₹10 Cr | ₹40 Cr | ₹362 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹4,430 Cr | ₹3,999 Cr | ₹2,707 Cr | ₹1,945 Cr | ₹2,052 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-13 Cr | ₹43 Cr | ₹-24 Cr | ₹-17 Cr | ₹-48 Cr |
| Raw Material Consumed | ₹654 Cr | ₹625 Cr | ₹607 Cr | ₹545 Cr | ₹532 Cr |
| Opening Raw Materials | ₹204 Cr | ₹222 Cr | ₹245 Cr | ₹342 Cr | ₹163 Cr |
| Purchases Raw Materials | ₹518 Cr | ₹456 Cr | ₹409 Cr | ₹389 Cr | ₹525 Cr |
| Closing Raw Materials | ₹234 Cr | ₹204 Cr | ₹222 Cr | ₹245 Cr | ₹342 Cr |
| Other Direct Purchases / Brought in cost | ₹166 Cr | ₹151 Cr | ₹176 Cr | ₹59 Cr | ₹187 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹93 Cr | ₹89 Cr | ₹82 Cr | ₹76 Cr | ₹61 Cr |
| Electricity & Power | ₹93 Cr | ₹89 Cr | ₹82 Cr | ₹76 Cr | ₹61 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹595 Cr | ₹525 Cr | ₹487 Cr | ₹445 Cr | ₹415 Cr |
| Salaries, Wages & Bonus | ₹537 Cr | ₹473 Cr | ₹438 Cr | ₹391 Cr | ₹353 Cr |
| Contributions to EPF & Pension Funds | ₹33 Cr | ₹29 Cr | ₹27 Cr | ₹26 Cr | ₹24 Cr |
| Workmen and Staff Welfare Expenses | ₹13 Cr | ₹11 Cr | ₹11 Cr | ₹14 Cr | ₹14 Cr |
| Other Employees Cost | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹14 Cr | ₹24 Cr |
| Other Manufacturing Expenses | ₹375 Cr | ₹368 Cr | ₹280 Cr | ₹354 Cr | ₹292 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹81 Cr | ₹70 Cr | ₹66 Cr | ₹60 Cr | ₹54 Cr |
| Packing Material Consumed | ₹48 Cr | ₹49 Cr | ₹44 Cr | ₹33 Cr | ₹28 Cr |
| Other Mfg Exp | ₹245 Cr | ₹249 Cr | ₹170 Cr | ₹261 Cr | ₹210 Cr |
| General and Administration Expenses | ₹304 Cr | ₹313 Cr | ₹209 Cr | ₹153 Cr | ₹117 Cr |
| Rent , Rates & Taxes | ₹54 Cr | ₹136 Cr | ₹56 Cr | ₹39 Cr | ₹37 Cr |
| Insurance | ₹35 Cr | ₹30 Cr | ₹28 Cr | ₹26 Cr | ₹20 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹152 Cr | ₹85 Cr | ₹73 Cr | ₹49 Cr | ₹30 Cr |
| Traveling and conveyance | ₹50 Cr | ₹50 Cr | ₹37 Cr | ₹22 Cr | ₹16 Cr |
| Other Administration | ₹13 Cr | ₹13 Cr | ₹15 Cr | ₹16 Cr | ₹14 Cr |
| Selling and Distribution Expenses | ₹136 Cr | ₹153 Cr | ₹96 Cr | ₹44 Cr | ₹34 Cr |
| Advertisement & Sales Promotion | ₹111 Cr | ₹133 Cr | ₹66 Cr | ₹33 Cr | ₹21 Cr |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | ₹26 Cr | ₹21 Cr | ₹30 Cr | ₹11 Cr | ₹13 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹91 Cr | ₹131 Cr | ₹59 Cr | ₹82 Cr | ₹46 Cr |
| Bad debts /advances written off | ₹1.10 Cr | ₹5.10 Cr | ₹11 Cr | ₹20 Cr | ₹12 Cr |
| Provision for doubtful debts | - | ₹23 Cr | - | ₹27 Cr | - |
| Losson disposal of fixed assets(net) | - | ₹1.70 Cr | - | - | - |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | ₹0.90 Cr | - | - | - |
| Other Miscellaneous Expenses | ₹90 Cr | ₹101 Cr | ₹48 Cr | ₹35 Cr | ₹34 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹2,236 Cr | ₹2,247 Cr | ₹1,795 Cr | ₹1,681 Cr | ₹1,448 Cr |
| Operating Profit (Excl OI) | ₹2,194 Cr | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr |
| Other Income | ₹357 Cr | ₹128 Cr | ₹129 Cr | ₹99 Cr | ₹106 Cr |
| Interest Received | ₹187 Cr | ₹101 Cr | ₹51 Cr | ₹39 Cr | ₹57 Cr |
| Dividend Received | ₹3.30 Cr | ₹0.30 Cr | ₹0.10 Cr | ₹0.20 Cr | - |
| Profit on sale of Fixed Assets | ₹90 Cr | - | ₹18 Cr | ₹43 Cr | ₹32 Cr |
| Profits on sale of Investments | ₹1.40 Cr | - | - | - | - |
| Provision Written Back | ₹2.20 Cr | - | ₹24 Cr | - | ₹2.40 Cr |
| Foreign Exchange Gains | ₹20 Cr | ₹10 Cr | ₹21 Cr | ₹10 Cr | ₹4.00 Cr |
| Others | ₹53 Cr | ₹17 Cr | ₹14 Cr | ₹6.80 Cr | ₹11 Cr |
| Operating Profit | ₹2,551 Cr | ₹1,880 Cr | ₹1,040 Cr | ₹363 Cr | ₹710 Cr |
| Interest | ₹24 Cr | ₹19 Cr | ₹15 Cr | ₹18 Cr | ₹13 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹6.90 Cr | ₹7.20 Cr | ₹5.00 Cr | ₹4.50 Cr | ₹4.00 Cr |
| Other Interest | ₹17 Cr | ₹12 Cr | ₹9.50 Cr | ₹13 Cr | ₹9.30 Cr |
| PBDT | ₹2,527 Cr | ₹1,860 Cr | ₹1,026 Cr | ₹345 Cr | ₹697 Cr |
| Depreciation | ₹235 Cr | ₹187 Cr | ₹164 Cr | ₹143 Cr | ₹117 Cr |
| Profit Before Taxation & Exceptional Items | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹2,291 Cr | ₹1,674 Cr | ₹862 Cr | ₹202 Cr | ₹580 Cr |
| Provision for Tax | ₹408 Cr | ₹285 Cr | ₹147 Cr | ₹32 Cr | ₹137 Cr |
| Current Income Tax | ₹430 Cr | ₹315 Cr | ₹163 Cr | ₹48 Cr | ₹141 Cr |
| Deferred Tax | ₹55 Cr | ₹-31 Cr | ₹38 Cr | ₹40 Cr | ₹14 Cr |
| Other taxes | ₹-77 Cr | ₹1.20 Cr | ₹-53 Cr | ₹-56 Cr | ₹-18 Cr |
| Profit After Tax | ₹1,883 Cr | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹442 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹2.00 Cr | - | - | - | ₹-1.50 Cr |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹1,885 Cr | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹441 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹4,466 Cr | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr | ₹2,239 Cr |
| Appropriations | ₹6,351 Cr | ₹4,681 Cr | ₹3,382 Cr | ₹2,738 Cr | ₹2,680 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹99 Cr | ₹213 Cr | ₹91 Cr | ₹-11 Cr | ₹16 Cr |
| Equity Dividend % | ₹300.00 | ₹475.00 | ₹275.00 | ₹225.00 | ₹262.50 |
| Earnings Per Share | ₹105.33 | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 |
| Adjusted EPS | ₹105.33 | ₹77.56 | ₹39.19 | ₹9.32 | ₹24.16 |
Compare Income Statement of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,081.1 Cr | 3.5% | 1.1% | -36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.5% |
1.1% |
-36.7% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses